Aimei Health Technology Co Ltd

Aimei Health Technology Co Ltd maintains a strong liquidity position, as evidenced by a current ratio of 6.13, indicating that the company has significantly more current assets than current liabilities. The company's total equity of $70.5 million is supported by total assets of $71.3 million, with no long-term debt, suggesting a conservative capital structure. The price-to-book ratio of 1.81 and price-to-tangible-book ratio of 1.81 indicate that the company's market value is slightly above its book value, which is in line with the industry norms for investment holding companies. In terms of profitability, the company reported a net income of $755,500 despite an operating loss of $153,630, which suggests that non-operating income or gains may have contributed to the bottom line. The return on equity (ROE) of 1.07% and return on assets (ROA) of 1.06% are below the industry median for investment holding companies, indicating that the company is not generating strong returns relative to its equity and asset base. The company's revenue is not disclosed in the provided data, and no specific segments or geographic regions are identified. However, the absence of detailed segment reporting is common for investment holding companies, which typically consolidate their operations under a single reporting line. The company's exposure to geographic and segment-specific risks is therefore not quantifiable from the available data. Looking ahead, the company's growth trajectory is not clearly defined in the provided data. The absence of forward-looking guidance and the lack of historical revenue data make it difficult to assess the company's growth potential. However, the company's strong liquidity position and low debt-to-equity ratio of 0 suggest that it is well-positioned to pursue new investment opportunities or weather economic downturns. The risk assessment indicates that the company faces low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt load and strong equity position reduce the likelihood of financial distress. However, the company's reliance on investment income exposes it to market volatility and the performance of its underlying assets. No dilution risks are currently flagged, and the company's share count has not changed between basic and diluted shares, indicating no imminent pressure from share issuance. No recent events, such as filings or transcripts, are provided in the data to indicate any material changes in the company's operations or strategy. The company's financial performance and risk profile appear to be stable, with no immediate red flags or significant developments reported in the available data.